Florence Tubach

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

D Emilie, F. Tubach, P. Ravaud, 2009, Arthritis and rheumatism.

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

D. Felson, I. Logeart, D. Heijde, 2004, Annals of the rheumatic diseases.

Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort

F. Tubach, L. Misery, A. Dupuy, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates.

P. Ravaud, Florence Tubach, B. Giraudeau, 2009, Journal of clinical epidemiology.

The variability in Minimal Clinically Important Difference and Patient Acceptable Symptomatic State values did not impact on treatment effect estimates

Florence Tubach, Tubach F, Giraudeau B, 2009 .